An updated guide to treating stroke

N. Schellack*, N. Smith, L. van Tonder, E. J. Fourie

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Stroke is one of the leading causes of mortality worldwide. Stroke can either be haemorrhagic (13%) or ischaemic (87%) in nature. Within the first few days of stroke, transient ischaemic attacks may occur and will require urgent intervention. However, this is often missed by healthcare workers. This article outlines the current evidence-based practice for stroke management and care. Based on the aetiology, this may include early reperfusion with a tissue plasminogen activator (t-PA), antiplatelet therapy and warfarin. This paper outlines many of the recommendations of the published National Clinical Guidelines for Stroke. It also covers aspects of multidisciplinary stroke care, from initial assessment and acute treatment, to rehabilitation strategies and the management of complications.

Original languageEnglish
Pages (from-to)26-34
Number of pages9
JournalSA Pharmaceutical Journal
Issue number4
Publication statusPublished - 1 Jan 2020


  • Haemorrhagic stroke
  • Hypertension
  • Ischaemic stroke
  • Reperfusion
  • Stroke
  • Tissue plasminogen activator


Dive into the research topics of 'An updated guide to treating stroke'. Together they form a unique fingerprint.

Cite this